A mouse model of metabolic syndrome; Increase in visceral adipose tissue precedes the development of fatty liver and insulin resistance in high-fat diet-fed male KK/Ta mice

Journal of Clinical Biochemistry and Nutrition

Volumn 42, Issue 2, 2008, Pages 150-157

  Akagiri, Satomi ^a   Naito, Yuji ^a   Ichikawa, Hiroshi ^b   Mizushima, Katsura ^a   Takagi, Tomohisa ^a   Handa, Osamu ^a   Kokura, Satoshi ^a   Yoshikawa, Toshikazu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY   (Japan)

Author keywords

Fatty liver; High fat diet; Metabolic syndrome; White adipose tissue

Indexed keywords

ADIPONECTIN; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; EXPERIMENTAL MODEL; FATTY LIVER; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIPID DIET; LIVER; MALE; METABOLIC SYNDROME X; MOUSE; NONHUMAN; OBESITY; PROTEIN EXPRESSION; RISK FACTOR; WHITE ADIPOSE TISSUE;

MUS;

EID: 46249111052     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.2008022     Document Type: Article

References (18)

1. Nestel, P., Lyu, R., Low, L.P., Sheu, W.H., Nitiyanant, W., Saito, I., and Tan, C.E.: Metabolic syndrome: recent prevalence in East and Southeast Asian populations. Asia Pac. J. Clin. Nutr., 16, 362-367, 2007.
2. Watanabe, S., Hojo, M., and Nagahara, A.: Metabolic syndrome and gastrointestinal diseases. J. Gastroenterol., 42, 267-274, 2007.
3. Shibata, G. and Tsuchiya, H.: Pathophysiology of NASH: insulin resistance, free fatty acids and oxidative stress. J. Clin. Biochem. Nutr., 38, 127-132, 2006.
4. Lara-Castro, C., Fu, Y., Chung, B.H., and Garvey, W.T.: Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease. Current Opinion in Lipidology, 18, 263-270, 2007.
5. Coenen, K.R. and Hasty, A.H.: Obesity potentiates development of fatty liver and insulin resistance, but not atherosclerosis, in high-fat diet-fed agouti LDLR-deficient mice. Am. J. Physiol. Endocrinol. Metab., 293, E492-499, 2007.
6. Nakamura, M.: A diabetic strain of the mouse. Proc. Japan Acad., 38, 348-352, 1962.
7. Nakamuara, N. and Yamada, K.: Studies on a diabetic (KK) strain of the mouse. Diabetologia, 3, 212-221, 1967.
8. Onat, A., Hergenc, G., Keles, I., Dogan, Y., Turkmen, S., and Sansoy, V.: Sex difference in development of diabetes and cardiovascular disease on the way from obesity and metabolic syndrome. Metabolism, 54, 800-808, 2005.
9. Buettner, R., Scholmerich, J., and Bollheimer, L.C.: High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity Silver Spring, Md., 15, 798-808, 2007.
10. Lee, J.Y., Sohn, K.H., Rhee, S.H., and Hwang, D.: Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J. Biol. Chem., 276, 16683-16689, 2001.
11. Shi, H., Kokoeva, M.V., Inouye, K., Tzameli, I., Yin, H., and Flier, J.S.: TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest., 116, 3015-3025, 2006.
12. Coenen, K.R., Gruen, M.L., Chait, A., and Hasty, A.H.: Diet- induced increases in adiposity, but not plasma lipids, promote macrophage infiltration into white adipose tissue. Diabetes, 56, 564-573, 2007.
13. Hu, E., Liang, P., and Spiegelman, B.M.: AdipoQ is a novel adipose-specific gene dysregulated in obesity. J. Biol. Chem., 271, 10697-10703, 1996.
14. Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., Kuriyama, H., Nishida, M., Yamashita, S., Okubo, K., Matsubara, K., Muraguchi, M., Ohmoto, Y., Funahashi, T., and Matsuzawa, Y.: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun., 257, 79-83, 1999.
15. Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., Ezaki, O., Akanuma, Y., Gavrilova, O., Vinson, C., Reitman, M.L., Kagechika, H., Shudo, K., Yoda, M., Nakano, Y., Tobe, K., Nagai, R., Kimura, S., Tomita, M., Froguel, P., and Kadowaki, T.: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med., 1, 941-946, 2001.
16. Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., Eto, K., Akanuma, Y., Froguel, P., Foufelle, F., Ferre, P., Carling, D., Kimura, S., Nagai, R., Kahn, B.B., and Kadowaki, T.: Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med., 8, 1288-1295, 2002.
17. Yamauchi, T., Kamon, J., Waki, H., Imai, Y., Shimozawa, N., Hioki, K., Uchida, S., Ito, Y., Takakuwa, K., Matsui, J., Takata, M., Eto, K., Terauchi, Y., Komeda, K., Tsunoda, M., Murakami, K., Ohnishi, Y., Naitoh, T., Yamamura, K., Ueyama, Y., Froguel, P., Kimura, S., Nagai, R., and Kadowaki, T.: Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J. Biol. Chem., 278, 2461-2468, 2003.
18. Cai, D., Yuan, M., Frantz, D.F., Melendez, P.A., Hansen, L., Lee, J., and Shoelson, S.E.: Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat. Med., 11, 183-190, 2005.